Dyne Therapeutics Inc (NAS:DYN)
$ 26 0.05 (0.19%) Market Cap: 2.27 Bil Enterprise Value: 1.85 Bil PE Ratio: 0 PB Ratio: 4.69 GF Score: 37/100

Dyne Therapeutics Inc at Jefferies London Healthcare Conference Transcript

Nov 16, 2022 / 12:20PM GMT
Release Date Price: $9.78 (-2.10%)
Eun Yang
Jefferies - Analyst

Good afternoon, everyone. This is Eun Yang, a biotech analyst with the Jefferies from the US.

So our next presenting company is Dyne Therapeutics. And joining me from Dyne today, Joshua Brumm, CEO and President; and Wildon Farwell, Chief Medical Officer. Thanks for joining us today.

So this is going to be a fireside chat. But before we do start the Q&A, so Josh, could you give us a quick overview about what Dyne is doing?

Joshua Brumm
Dyne Therapeutics, Inc. - President & CEO

Sure.

Eun Yang
Jefferies - Analyst

Thank you.

Joshua Brumm
Dyne Therapeutics, Inc. - President & CEO

Sure. Thanks. First of all, thanks, Eun, for inviting us today to be here. It's great, great always to tell the Dyne story.

We may be making some forward-looking statements. So if you have any questions around our forward-looking statements, please look at our SEC filings for some more on that matter.

In regards to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot